Photobiomodulation at 660 nm Stimulates Fibroblast Differentiation
Mokoena DR, Houreld NN, Dhilip Kumar SS, Abrahamse H
Lasers in surgery and medicine · 41 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- In vitro/mechanistic study (classified by our AI screen)
- Studied in
- Cells or lab samples
- Main outcome
- Mechanisms only
Who paid for it
- Funding
- Independent funding
- Government
- National Research Foundation
- University or hospital
- University of Johannesburg
- Grants
- National Research Foundation (112114); University of Johannesburg (020930)
Based on 2 listed funder(s).
Publication
- Published
- 2019-12-09 · Lasers Surg Med · vol. 52 · issue 7 · pp. 671–681
- Publisher
- Wiley
- Cited
- 51 citations · more than 93% of similar papers · 3.6× the field average
- Impact
- Top 10% most cited in its field
- References
- 37 works
- Access
- Paywalled
- Research areas
- Laser Applications in Dentistry and Medicine · Wound Healing and Treatments · Medical and Biological Ozone Research
- Keywords
- Fibroblast, Chemistry, Cell biology, Biology, Biochemistry, In vitro
- MeSH
- cells, cultured, fibroblasts, humans, wound healing, cell differentiation, cell survival, myofibroblasts
4 authors
From ZA
- Dimakatso R. MokoenaUniversity of Johannesburg
- Nicolette N. Houreld · correspondingUniversity of Johannesburg
- Sathish Sundar Dhilip KumarUniversity of Johannesburg
- Heidi AbrahamseUniversity of Johannesburg
Abstract
Background and objectives
Among many of the different complications that diabetic patients suffer, foot ulcers are the most challenging, and in many cases result in non-traumatic lower limb amputation and permanent disability. To alleviate this burden, new interventions such as photobiomodulation (PBM) have been utilized. However, the cellular pathways affected by PBM have not yet been fully recognized. The differentiation of fibroblasts into myofibroblasts forms a vital part of wound healing and is often impaired under diabetic conditions. Therefore, this study sought to investigate the effects of PBM at 660 nm on the transforming growth factor-β1 (TGF-β1)/Smad pathway and the differentiation of fibroblasts into myofibroblasts.
Study design/materials and methods
WS1 fibroblasts were treated with PBM using a wavelength of 660 nm at a fluence of 5 J/cm2 in normal, normal wounded, diabetic, and diabetic wounded models. Post-irradiation cellular responses were observed at 24, 48, and 72 hours to ascertain morphological changes and cell viability, and the expression of fibroblast differentiation markers (Thy-1 or CD90, extra domain A fibronectin or EDA-FN and α-smooth muscle actin or α-SMA), TGF-β1, phosphorylated (p)TGF-β receptor 1 (R1), and p-Smad2/3.
Results
There was a significant increase in cell viability in all irradiated cell models, and no real significant changes in TGF-β1, pTGF-β1R1, and p-Smad2/3. As incubation time post-irradiation increased, Thy-1 (CD90) decreased, while EDA-FN and α-SMA increased in wounded models.
Conclusions
PBM at 660 nm with 5 J/cm2 was successful in stimulating the differentiation of fibroblasts into myofibroblasts in diabetic wounded cells, which was independent of the TGF-β1/Smad pathway. Fibroblast transition into myofibroblasts is vital to wound healing, failure of which results in impaired healing; PBM is able to foster such a transition. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.